In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 2, 1999, Pages 187-192

  Ringwald, Pascal ^a   Bickii, Jean ^a   Basco, Leonardo K ^a  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISIN; CHLOROQUINE; DEETHYLAMODIAQUINE; DIHYDROARTEMISININ; DRUG METABOLITE; HALOFANTRINE; MEFLOQUINE; PYRIMETHAMINE; QUININE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CAMEROON; CONTROLLED STUDY; CORRELATION FUNCTION; CROSS RESISTANCE; IN VITRO STUDY; NONHUMAN; PLASMODIUM FALCIPARUM;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032777790     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.187     Document Type: Article

References (48)

1. Klayman DL, 1985. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228: 1049-1055.
2. Qinghaosu Antimalarial Coordinating Research Group, 1979. Antimalaria studies on qinghaosu. Chin Med J 92: 811-816.
3. Hien TT, White NJ, 1993. Qinghaosu. Lancet 341: 603-608.
4. de Vries PJ, Dien TK, 1996. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 52: 818-836.
5. World Health Organization, 1994. The Role of Artemisinin and its Derivatives in the Current Treatment of Malaria (1994-1995). WHO/MAL/94.1067.
6. Looareesuwan S, Viravan C, Vanijanonta S, Wilairalana P, Suntharasamai P, Charoenlarp P, Arnold K, Kyle D, Canfield C, Webster K, 1992. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 339: 821-824.
7. Price RN, Nosten F, Luxemburger C, Kham AM, Brockman A, Chongsuphajaisiddhi T, White NJ, 1995. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 89: 523-527.
8. Bunnag D, Kanda T, Karbwang J, Thimasarn K, Pungpak S, Harinasuta T, 1996. Artemether or artesunate followed by mefloquine as a possible treatment for multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 90: 415-417.
9. Sabchareon A, Attanath P, Chanthavanich P, Phanuaksook P, Prarinyanupharb V, Poonpanich Y, Mookmanee D, Tejaisavadharm P, Heppner DG, Brewer TG, Chongsuphajaisiddhi T, 1998. Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria. Am J Trop Med Hyg 58: 11-16.
10. Duarte EC, Fontes CJ, Gyorkos TW, Abrahamowicz M, 1996. Randomized controlled trial of artesunate plus tetracycline versus standard treatment (quinine plus tetracycline) for uncomplicated Plasmodium falciparum malaria in Brazil. Am J Trop Med Hyg 54: 197-202.
11. Looareesuwan S, Wilairatana P, Vannaphan S, Gordeuk VR, Taylor TE, Meshnick SR, Brittenham GM, 1996. Co-administration of desferrioxamine B with artesunate in malaria: an assessment of safety and tolerance. Ann Trop Med Parasitol 90: 551-554.
12. Na-Bangchang K, Tipwangso P, Thanavibul A, Tan-Ariya P, Suprakob K, Kanda T, Karbwang J, 1996. Artemether-pyrimethamine in the treatment of pyrimethamine-resistant falciparum malaria. Southeast Asian J Trop Med Public Health 27: 19-23.
13. van Vugt M, Brockman A, Gemperli B, Luxemburger C, Gathmann I, Royce C, Slight T, Looareesuwan S, White NJ, Nosten F, 1998. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob Agents Chemother 42: 135-139.
14. Lee IS, Hufford CD. 1990. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther 48: 345-355.
15. White NJ, 1994. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans R Soc Trop Med Hyg 88 (suppll): S41-S43.
16. Batty KT, Thu LTA, Davis TME, Ilett KF, Mai TX, Hung NC, Tien NP, Powell SM, Thien HV, Binh TQ, Kim NV, 1998. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated malaria. Br J Clin Pharmacol 45: 123-129.
17. Grace J, Aguilar AJ, Trotman KM, Brewer TG, 1998. Metabolism of beta-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450. Drug Metab Disp 26: 313-317.
18. Batty KT, Ilett KF, Davis TME, 1996. Chemical stability of artesunate injection and proposal for its administration by intravenous infusion. J Pharm Pharmacol 48: 22-26.
19. Brossi A, Venugopalan B, Dominguez-Gerpe L, Yeh HJC, Flippen-Anderson JL, Buchs P, Luo XD, Milhous W, Peters W, 1988. Arteether, a new antimalarial drug: synthesis and antimalarial properties. J Med Chem 31: 645-650.
20. Looareesuwan S, Wilairatana P, Vanijanonta S, Pitisuttithum P, Viravan C, 1996. Treatment of acute, uncomplicated, falciparum malaria with oral dihydroartemisinin. Ann Trop Med Parasitol 90: 21-28.
21. Ringwald P, Bickii J, Basco LK, 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Am J Trop Med Hyg 55: 254-258.
22. Basco LK, Bickii J, Ringwald P, 1998. In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Antimicrob Agents Chemother 42: 2347-2351.
23. Mount DL, Nahlen BL, Patchen LC, Churchill FC, 1989. Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull World Health Organ 67: 295-300.
24. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, 1979. Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique. Antimicrob Agents Chemother 16: 710-718.
25. Ringwald P, Bickii J, Basco L, 1996. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347: 24-28.
26. Ringwald P, Bickii J, Basco LK, 1998. Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children. Clin Infect Dis 26: 946-953.
27. Ringwald P, Bickii J, Basco LK, 1998. Amodiaquine as the first-line treatment of malaria in Yaoundé, Cameroon: presumptive evidence from activity in vitro and cross-resistance patterns. Trans R Soc Trop Med Hyg 92: 212-213.
28. Basco LK, Ringwald P, 1998. Molecular epidemiology of malaria in Yaoundé, Cameroon. I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg 58: 369-373.
29. Basco LK, Ringwald P, 1998. Molecular epidemiology of malaria in Yaoundé, Cameroon. II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg 58: 374-377.
30. Basco LK, Tahar R, Ringwald P, 1998. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites. Antimicrob Agents Chemother 42: 1811-1814.
31. Louis FJ, Fargier JJ, Maubert B, Louis JP, Hounsinou C, Le Bras J, Touze JE, 1992. Accès palustre grave de l'adulte au Cameroun: comparaison de deux protocoles thérapeutiques utilisant la quinine par voie parenterale. Ann Soc Belg Med Trop 72: 179-188.
32. Ringwald P, Louis FJ, Bickii J, Ringwald C, Daban A, Ravinet L, 1995. Efficacy and tolerance in adults of a short (3 days) course of quinine therapy for uncomplicated falciparum malaria. Ann Soc Belg Med Trop 76: 139-141.
33. Fadat G, Louis FJ, Louis JP, Le Bras J, 1993. Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon. Antimicrob Agents Chemother 37; 1955-1957.
34. Basco LK, Ramiliarisoa O, Le Bras J, 1995. In vitro activity of atovaquone (566C80) against the African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 53: 388-391.
35. Shmuklarsky MJ, Klayman DL, Milhous WK, Kyle DE, Rossan RN, Ager AL, Tang DB, Heiffer MH, Canfield CJ, Schuster BG, 1993. Comparison of β-artemether and β-arteether against malaria parasites in vitro and in vivo. Am J Trop Med Hyg 48: 377-384.
36. Wernsdorfer WH, 1994. Epidemiology of drug resistance in malaria. Acta Trop 56: 143-156.
37. Basco LK, Le Bras J, 1993. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 49: 301-307.
38. Bustos MDG, Gay F, Diquet B, 1994. In vitro tests on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives. Bull World Health Organ 72: 729-735.
39. Gay F, Ciceron L, Litaudon M, Bustos MD, Astagneau P, Diquet B, Danis M, Gentilini M, 1994. In vitro resistance of Plasmodium falciparum to qinghaosu derivatives in West Africa. Lancet 343: 850-851.
40. Wongsrichanalai C, Dung NT, Trung TN, Wimonwattrawatee T, Sookto P, Heppner DG, Kawamoto F, 1997. In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials. Acta Trop 63: 151-158.
41. Wernsdorfer WH, Payne D, 1991. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther 50: 95-121.
42. ter Kuile FO, Dolan G, Nosten F, Edstein MD, Luxemburger C, Phaipun L, Chongsuphajaisiddhi T, Webster HK, White NJ, 1993. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet 341: 1044-1049.
43. Basco LK, Eldin de Pécoulas P, Wilson CM, Le Bras J, Mazabraud A, 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69: 135-138.
44. Pradines B, Rogier C, Fusai T, Tall A, Trape JF, Doury JC, 1998. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. Am J Trap Med Hyg 58: 354-357.
45. Hong YL, Yang YZ, Meshnick SR, 1994. The interaction of artemisinin with malarial hemozoin. Mol Biochem Parasitol 63: 121-128.
46. Cumming JN, Ploypradith P, Posner GH, 1997. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv Pharmacol 37: 253-297.
47. Chen Y, Zhu SM, Chen HY, Li Y, 1998. Artesunate interaction with hemin. Bioelectrochem Bioenerg 44: 295-300.
48. ++-induced cleavage of qinghaosu and derivatives/analogues. The first spin-trapping evidence for the previously postulated secondary C-4 radical. J Am Chem Soc 120: 3316-3325.